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ABSTRACT 
Breast cancer patients undergoing radiotherapy often experience severe levels of anxiety and depression within the African 
context. There is a gap in the research literature from Africa, particularly Ghana, with few studies focusing on depression among 
patients undergoing radiation treatment. The purpose of the study was to find various interventions for depression and anxiety 
among breast cancer patients in Ghana. A mixed method study examined breast cancer patients undergoing radiotherapy and 
their responses through a concurrent triangulation involving an interview with selected professional and a detailed patient survey. 
In all, 100 patients between the ages of 20-89 completed a questionnaire and individual interviews were held with 6 professionals 
with a minimum of 5 years of work experience. Themes were generated through open coding of the interview data, while multiple 
regression was performed to determine the relationship between depression and anxiety with the independent variables. In all, 
89% had no family history of breast cancer, and the majority (55%) had the disease duration of one to three years. Almost 95% 
of patients with breast cancer had anxiety and depression in different categories. This included hair loss, discolored finger nails, 
cost of treatment, and fear of the unknown. Age and monthly income of patients were statistically significant in predicting the 
anxiety and depression among the patients. Coping mechanisms are essential for all patients undergoing treatment. This study’s 
implications will lead to positive change when all stakeholders assist in implementing measures to promote coping strategies for 
breast cancer patients in Ghana. 
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Anxiety is the feeling of fear, distress, and uneasiness of an 
imminent endangerment whiles depression is a symptom 
expressed through tireless sensations of hopelessness, 
unhappiness, lack of concentration, lack of energy, and 
insomnia, especially with a cancer diagnosis (Healthline, 
2015). Breast cancer is the most common cancer among 
women globally according to Ward et al., (2015) and the 
World Health Organization (WHO) predicted it as the most 
likely reason a woman will die of cancer (WHO, 2007). WHO 
(2013) in their 2013 global estimates indicated that cancer of 
the breast was common in both the developing and the 
developed world with an estimated average of over 508 000 
deaths every year. According to studies done in Ghana by 
Wiredu & Armah, (2006) and Biritwum & Amaning, (2000) 
breast cancer is the common cause of mortality and most 
hospital admissions among Ghanaian women.   
 Several studies have demonstrated that patients are usually 
at greater risk of developing psychological distress leading to 
some level of anxiety and depression (Schetter and Tanner 
2012; Vin-Raviv et al, 2015). Among the study population, 
anxiety and depression are the most dominant symptoms that 
are usually under predicted and undertreated from 
observations. Breast cancer treatment and its related cost are 
financially straining for patients and their caregivers in Ghana 
(Kyei et al, 2015). Referrals are delayed unnecessarily due to 
patient’s noncompliance and cost of treatment amongst other 
things (Arvidsdotter et al, 2015). 
 According to studies by Coolen, (2012) and Institute of 
Medicine Committee on Psychosocial Services to Cancer 
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Patients/Families in a Community Setting, (2008) clients 
receiving treatment have fears and concerns regarding 
mortality. Other studies have suggested that families do suffer 
from the effects of depression in patients undergoing treatment 
(Watts et al, 2015; Birnie et al, 2010) and the phase of 
emotional shock and disbelief is common as part of the 
patient’s psychological characteristics after a diagnosis is 
made, followed by anxiety. According to Joffe et al., (2012) 
anxiety and depression reduces the lifespan of patients, affects 
their overall quality of life, lead to increased mortality, and 
disturbs their daily functioning. 
 What is missing in the literature is studies that focuses on 
determining levels of anxiety and depression, and how this 
assessment impact treatment outcome for breast cancer 
patients undergoing radiotherapy. The aim of the study was to 
find various interventions for anxiety and depression among 
the selected patients in Ghana focusing on the on health 
professionals’ views of their own practice and the response 
they receive from patients. According to a study by Kyei, et 
al., (2015) the majority of breast cancer patients undergoing 
treatment at the study site were dissatisfied with the radiation 
treatment they received. This unsatisfactory nature was 
evidenced by the various degrees of complaints leading to 
intensification in the patients’ levels of anxiety and triggering 
many levels of depression. This study elucidated the various 
interventions required to minimize depression and anxiety 
among breast cancer patients undergoing radiation therapy in 
Ghana. 
 
MATERIALS AND METHODS 
 
Study design: The study approach was a mixed method 
design to gather both quantitative and qualitative data. Data 
were collected from selected patients and staff included 
coping strategies, and approaches for management.  
 
Ethical consideration: This study has been reviewed by the 
ethics and protocol review committee of a higher institution 
and the head of unit of the study site and has been performed 
in accordance with the ethical standards laid down in an 
appropriate version of the 2000 Declaration of Helsinki as 
well as the Declaration of Istanbul 2008. All persons gave 
their informed consent prior to their inclusion in the study. 
Any details that sought to disclose the identity of the subjects 
under the study was omitted. The Institutional Review Board 
(IRB) of the Walden University in the United States assessed 
the research as meeting the requirements and complying with 
standards for data collection in the hospital in Ghana. 
Approval was granted (no: 06-07-17-0475898) and was 
further accepted by the Oncology Unit in Ghana.  
 
Participants selection: The qualitative data were interviews 
with selected staff who worked with patients (radiation 
therapists (RT), doctors (D), and nurses (N). The quantitative 
data was a descriptive survey with questionnaire using a 
sample of 100 participants. The selection of the professional 
participants was from a pool of over 30 staff with a minimum 
work experience of 5 years. The reason was that with 5 years’ 
professional experience, the staff should be able to assess 
patients thoroughly, manage treatment symptoms, and 
perform complete treatment for patients. A minimum sample 
calculation was used for the selection of the patients with n = 
[Z²p (1-p)]/E², where, n = minimum sample size, p = 
population proportion of the breast cancer patients available 
during the time of the study (195/400), Z = confidence level 
of 95%, and E = the maximum allowable error (5%). By the 
calculation, n =90 and the selected sample size was 100 for the 
period. 
 
Location: The study took place at the oncology department in 
Accra, Ghana between the months of June and August 2017. 
This site was chosen because it serves a total of 70% of all 
cancer cases seen in the country (Kyei et al, 2015). The use of 
convenience sampling was because it offered the authors 
access to both participants.  
 
Instrument and data collection: A semi-structured 
questionnaire that was a modified version of Patient Health 
Questionnaire and Depression Anxiety Stress Scale was used 
to collect data from the patients whereas interviews were used 
to collect data from the professionals. Administration of the 
questionnaire took place in the control room where patients 
are called to before the commencement of their procedure. 
Patient demographics such as the age, sex, education, marital 
status, and income level were measured and used as 
independent variables. The period of treatment, waiting times, 
type of cancer, and the remedy for the anxiety and depression 
experienced were measured as well. Open-ended questions 
through conversations in a format of mutual understanding 
occurred among the professionals.  
 The theoretical basis for this study was the Health Action 
Process Approach (HAPA) which is a psychosomatic change 
theory of health behavior developed by Schwarzer, (2008). 
The HAPA postulated two distinct stages, a motivation or pre-
intentional phase and a volition or self-regulatory or action 
phase. The HAPA was used to predict, describe, and explain 
breast cancer treatment processes that lead to anxiety and 
depression. 
 
Data Analysis: Interview data were analyzed using the NVivo 
version 11 for Mac by QSR International through transcribing, 
finding emerging themes, coding, and making connections to 
the focus of the study. The quantitative data was exported into 
Microsoft excel and analyzed using IBM SPSS Statistics 
(Version 22, Armonk, NY, USA) to evaluate the relationships 
between the responses of breast cancer patients on their 
treatment and their level of anxiety and depression. Multiple 
regression analyses on the quantitative data were performed. 
Responses in frequencies for the questionnaire were 






The results were in two categories, the qualitative data through 
interviews from the 6 professionals (N1, N2, RT1, RT2, D1 and 
D2) and quantitative through questionnaires from the 100 
patients. 
Qualitative Data 
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In all, 33.3% of participants were females (representing 2/6), 
and 67.7% were males. The average working year was 7, with 
doctors having the least professional years of experience (5 
years). The themes generated from the responses covered 
areas such as (a) complaints, (b) interventions prescribed, and 
(c) management. 
The complaints included distress, burden of disease, fear of 
the unknown, and cost of treatment. In trying to understand 
these complaints, some of the responses gathered from 
interview questions are in Box 1:   
 In terms of interventions, participants indicated what they 
do and these are summarized in Box 2. In Box 3, the 
management of anxiety and depression as discussed by 
participants as they interacted with their patients were: the 
need for a psychotherapist, prayer, physical therapist or 
exercise, and finally medications. 
 
BOX 1 
• Their financial commitment to the treatment is high and the 
chemotherapy drugs are very costly. (RT1) 
• The overall treatment is way too expensive for an average 
Ghanaian. This will be too hard for them to pay. (D2) 
• Financial burden of patients affect the information they receive 
in the clinic. (D1)  
• Patients’ financial burden is worrying, most of them are traders 
and they earn very little (N1) 
• According to her, she lost her hair, finger nails were burnt, and 
had several issues with the drugs, which was distressing for her. 
(N2)  
• Seeing machines at the treatment unit is enough to scare them 
through their treatment trajectory. (D1)  
• This in effect increases their anxiety and depression as they are 
constantly afraid (N2) 
• She was afraid of developing a heart attack because somebody 




• I try to reassure, educate and encourage them to complete their 
treatment. (D1)  
• I prescribe some medications for them sometimes, and some 
even get sleeping tablets because they complain of sleep 
impairment. I give assistance in the form of introductory letters 
on request from patients to their work places for financial 
support. (D2)  
• Explaining what the process is all about, and letting them know 
that, though the machines may be scary, it will not harm them. 
(RT,2) 
• I inform them that they are always monitored when treatment 
is ongoing and when they speak, we can hear them, so they 
should not fear. (RT1,)  
• I inform them that if they are in any form of distress during 
treatment, they should signal us and then I will come to their 
aid. I also advise them to get relief or excuse duty from work. 
(N2) 
• The first stage is the counseling for the patients, I discuss every 
possible side effect to patients. I try to debunk any negative 
information they may have heard from people concerning the 
treatment, like “you will die’, they will cut your breast,' ‘your 
hair will be gone’ and the likes. (N1) 
 
 
A word frequency query run indicated words like patients, 
treatment, and anxiety (Figure 1). There were also words like 
interventions, depression that showed up boldly 
 
BOX 3 
• Responses from five out of the six participants indicated the 
need for a psychotherapist with the Oncology department in 
Ghana. (N2, RT1,2, D1,2)   
• Two participants mention pastors and prayer. (N1,2) 
• Two of the participants spoke about the need for physiotherapy. 
(D1, R2) 
• One of the doctors mentioned about prescription of drugs for 
patients at some point 
 
 
Figure 1.  
Word Frequency on Anxiety and Depression among Participants 
 
Quantitative Data 
All the 100 patient participants (n=100) responded to the 
questionnaires with age group between 20-89 years. The 
group 50-59 years had the highest frequency of 28% whiles 
the least was 80-89 years. The married had the highest 
frequency (73%). With the employment status, 51% of the 
participants were full-time workers whiles 41% were not into 
any job as well. In all, 89% had no family history of breast 
cancer, and the majority (55%) had the disease duration of one 
to three years. Forty-one percent were not into any job and 
another 21% had a monthly income of less than a thousand 
Ghana Cedi (which is less than 300 USD).  
 The chi square of the monthly income of patients with 
anxiety and depression was 1.47, and the p-value was 0.5. This 
indicates that income of patients has an effect on anxiety and 
depression. In Table 1, Age (B = -0.094, ß =-0.280, t = -0.269, 
p < 0.05), and monthly income (B = -0.923, ß =-0.302, t =-
2.081, p < 0.05) were statistically significant in predicting the 
anxiety and depression among the patients as compared to the 
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rest of the variables. The beta value for disease duration, 
marital status, and tribe indicate that anxiety and depression 
on treatment increases respectively holding all other variables 
constant (0.76, 0.157, 0.160) showing a positive relationship. 
The VIF is less than 3 for all variables, meaning that there is a 
positive correlation. Hence, the assumptions are met, and 
therefore the conclusion is that the independent variables are 
not confounding. All other things equal, these lower levels of 
VIF, indicate a positive effect on anxiety and depression 
associated with a multiple regression analysis.  
 
Table 1:  
Regression Analysis for Anxiety and Depression compared with 
key Variables 
A. Descriptive Statistics 
         
Mean 
          Std. 
Deviation 





14.36 4.595 94 
Age 51.32 13.641 94 
Weight 72.76 16.063 94 
Gender 2.00 .000 94 
Tribe 2.49 1.515 94 
Marital status 2.19 .766 94 
Employment 
status 
2.38 1.496 94 
Monthly income 1.21 1.502 94 
Disease duration 2.22 .658 94 
Family history 1.93 .302 94 
    
Beneath the table lets add R=0.078, Age (B = -0.094, ß =-0.280, t = 
-0.269, p < 0.05), and monthly income (B = -0.923, ß =-0.302, t 
=2.081, p < 0.05) 
 
R (0.397) was found to be less than 0.5, indicating that there 
is a change in the model. The alternate hypothesis is therefore 
accepted since the independent variables significantly 
predicted anxiety and depression. An ANOVA was conducted 
for anxiety and depression as the dependent factors and 
demographic as the predictors. A greater percentage (30.7%) 
of the patients indicated meditation as their intervention while 
few (9.4%) were of the view that their doctors referred them 
for counseling (Figure 2). Anxiety and depression were 
evident during treatment and daily life of patients (Table 2). 
 
Table 2 
Treatment and life frequencies of patients undergoing Radiotherapy 
 Responses 
    N Percent 
Anxiety and 
Depression on life 
not at all 313 17.4% 
several days 778 43.3% 
more than half 
the days 
556 30.9% 
nearly everyday 150 8.3% 




not at all 46 5.1% 
several days 414 46.1% 
more than half 
the days 
327 36.4% 
nearly everyday 111 12.4% 





The study sought to address a gap in the literature by 
identifying significant relationships between the responses of 
breast cancer patients undergoing radiotherapy treatment and 
their various levels of anxiety and depression, as well as their 
treatment responses. The experiences of patients as reported 
by the participants cut across complaints from patients, 
interventions prescribed, and management. Patients also 
responded to the effect of breast cancer, and the impact of cost 
on their treatment leading to their anxiety and depression. 
Interventions as well as the management cover both the 
interviews and the survey. 
 
Figure 2.  
Interventions of anxiety and depression among patients on treatment 
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 The interviews with the professionals did support the 
responses from the patient participants. These supports were 
in three sections on the experiences of breast cancer patients 
undergoing and how it affected breast cancer patients 
undergoing treatment. The first was on the complaints that 
directly affected daily life of the patients. These complaints 
covered the burden of disease, fear of the unknown, and cost 
of treatment. This was evident in the responses by the patients 
on their daily treatment and life in general. The second and the 
third were interventions and management that were prescribed 
and suggested by professionals and patients respectively. 
 Almost 95% of patients with breast cancer had anxiety and 
depression in different categories (Table 2 and 3). This result 
was very high compared to studies conducted Baqutayan, 
(2012) and Hassan et al., (2015). The first explanation could 
be the late stage of presentation, the high cost of treatment, 
lack of financial support, lack of insurance, inadequate family 
support, family dejections, ignoring by spouses, separation, 
divorce, fear, and the fact that some think it is communicable 
as described by the professional participants during the 
interviews. The burden also included the loss of hair, 
discolored finger nails, and various issues with cytotoxic 
drugs. Hair loss (alopecia), because it is visible to others, can 
cause considerable distress for patients. The crown of hair is 
part of the patient’s self-image and can affect the patient’s 
confidence. A recommended solution suggested by the Breast 
Cancer Network Australia (2011) was that patients have to be 
prepared thoroughly by the caregiver before the treatment, and 
individual patients should talk about it with others such as 
family and friends. Counseling and consent prior to treatment 
should include issues of disfigured and darkening of their 
fingers and nail beds. This education could help patients cope 
with the changes that occur (Canadian Cancer Society, 2017). 
 Another report from one of the participants was the 
treatment related fear exhibited by patients. Treatment of the 
breast and lymphatic drainage will undoubtedly involve some 
vital organs such as lung and heart. However, the treatment 
plan with proper calculation of the doses demonstrates how 
much each organ within the treated field is receiving and 
ensures that reference tolerance levels of each organ at risk is 
respected. All these will have to be communicated properly to 
patients during counseling and consent to avoid situations and 
comments from patients such as these.  
 According to the professional participants, the burden of 
the disease resulted from the high financial commitment from 
patients which is one of the indicators of anxiety and 
depression. Treatment cost of breast cancer ranges between 
1,500 - 3,000 USD and the reports from the study indicated 
that such money was too high for average patient. Again, the 
overall treatment cost could be much higher when 
chemotherapy and hormonal therapy are prescribed or 
combined with the radiotherapy. With findings of about 41% 
of patients without any salary or income and a further 21% 
with less than 300 USD, the cost of treatment was a burden 
and affected patient level of anxiety and depression. These 
findings were in agreement with a study by Opoku et al., 
(2012) which indicated that financial burden could 
significantly affect the overall treatment outcome for patients 
undergoing treatment. 
 Various intercessions made by the professional 
participants for patients whiles they were on treatment were 
reassurances, explanations of the entire treatments and side 
effects, and counseling. Other interventions were 
encouragement, advice (such as doing something they love 
doing, get relief from work, and relaxation), monitoring, 
coping, debunking any negative pieces of information from 
them, prescriptions for medications, and on few occasions, 
referring to counselors outside the department. These 
interventions were confirmed by the patients undergoing 
treatment although they indicated very little information on 
counseling and medication from their caregivers to help them 
cope with the treatment (Figure 2). As a result of this, many 
of the responses indicated that patients resorted to meditation 
and prayers for management of their anxiety and depression. 
The results show the importance of religiosity and spirituality 
in coping with a cancer diagnosis within the African context 
(Ikeoluwapo et al, 2016). Another comment from patients as 
reported by the participants was feeling fatigued after 
treatment, and more apprehensive after explanations. Patients 
become less anxious when they know what is wrong with 
them, how treatment will be delivered when proper 
explanations on the side effects is given and the more 
importantly what to do as and when an issue arises. Both 
participants involved in the study indicated the need for 
counselors or psychotherapist, spirituality or prayer, 
medication, and physical therapy.  
 The theoretical basis for this study using the framework 
HAPA buttressed the inputs provided in the survey that 
informs preventive or coping for patients undergoing anxiety 
and depression. This model was used to describe breast cancer 
treatment processes from the onset of the diagnosis, through 
treatment and the aftermath of treatment. The theory helped 
predict factors that led to anxiety and depression both from 
patients and professionals. Finally, this theory assisted in 
explaining the interventions and management of breast cancer 
within the context of the setting of the study.  
 In conclusion, there is a significant relationship between 
the responses of breast cancer patients undergoing 
radiotherapy and their level of anxiety and depression. 
Patients undergoing breast cancer treatment go through 
several experiences such as the burden of the treatment, high 
cost of treatment, and waiting time, resulting in high-level 
anxiety and depression. Late presentation to treatment is 
common in Ghana as a consequence of the multiplicity of 
reasons, affecting the overall survival of breast cancer 
patients. The effect sizes of the selected participants show 
strength of relationship though not every variable was 
statistically significant to patients’ level of anxiety and 
depression. Further and future research with a larger sample 
size of patients from all the three Oncology departments 
within the country would shed more light on the relationships 
examined in this study. This study is imperious to promoting 
the scholarly research concerning the complete translation of 
the coping strategies in handling anxiety and depression. 
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